FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

ANI Pharmaceuticals Estradiol Gel Recall

Estradiol Gel, 0

ANI Pharmaceuticals, Inc. · Baudette, MN

Risk level
Class II
Reported by FDA
May 27, 2026
Recall ID
D-0543-2026
Check your lot numberHow we source this data

Summary

ANI Pharmaceuticals recalled Estradiol Gel starting May 12, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0543-2026 on May 27, 2026. Reason: Defective Container; packets were found to be either empty or partially full. Status: Ongoing.

Why it was recalled

Defective Container; packets were found to be either empty or partially full.

Product description

Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20

Lot numbers, UPCs & expiration codes

Lot M251109, exp Nov 2027

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0543-2026
Classification
Class II
Status
Ongoing
Recall initiated
May 12, 2026
FDA report date
May 27, 2026
Quantity
3964 Cartons
Recall type
Voluntary: Firm initiated
Recalling firm
ANI Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0543-2026, exactly as published.

Show all FDA fields
City
Baudette
State
MN
Status
Ongoing
Country
United States
Event ID
98947
Address
210 W Main St
Code information
Lot M251109, exp Nov 2027
Postal code
56623-2467
Report date
May 27, 2026
Product type
Drugs
Recall number
D-0543-2026
Classification
Class II
Recalling firm
ANI Pharmaceuticals, Inc.
Product quantity
3964 Cartons
Reason for recall
Defective Container; packets were found to be either empty or partially full.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20
Distribution pattern
Nationwide in the USA
Recall initiation date
May 12, 2026
Initial firm notification
Letter
Center classification date
May 20, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0543-2026, published May 27, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls